HealthyPlan n/a · Option n/aFit for a long SIP
Mirae Asset Nifty India Manufacturing ETF
Mirae Asset Mutual FundExchange Traded Funds (ETFs) - Equity ETF4.8 years
- NAV
- 152.4255
- 29 Oct 2026
- 1Y
- -2.0%
- Trailing CAGR
- AUM
- ₹248.93 Cr
- 30 Jun 2026
- Volatility
- Medium
- 15.6% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
4.8 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -23.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 23%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-2.0%
- 3Y+16.7%
- 5Yn/a
- 10Yn/a
- SI+15.1%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-5.5%
- 3Y+5.8%
- 5Yn/a
- 10Yn/a
- Since inception
- +15.1%
- Calendar-day CAGR
- Excess 1Y
- +4.4%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 81
- Vs comparable share classes
- SIP 3Y XIRR
- +5.8%
- Simulated monthly SIP
- Worst rolling 3Y
- +14.3%
- 435 daily-ending windows
- Median rolling 3Y
- +21.5%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -23.2%
- Worst peak-to-trough
- Current
- -10.1%
- Below last peak
- Current spell
- 83 days
- Days below latest peak
- Time below peak
- +87%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 15 days
- 54 recovered episodes
- Longest recovery
- 310 days
- Trough to prior peak
27 Sept 2024 – 11 Feb 2026
Trough 7 Apr 2025 · recovered in 310 days
-23.2%
11 Apr 2022 – 10 Aug 2022
Trough 20 Jun 2022 · recovered in 51 days
-15.6%
7 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.9%
26 Feb 2026 – 6 May 2026
Trough 31 Mar 2026 · recovered in 36 days
-12.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
82
Vs category
78
Consistency
90
Risk-adjusted
56
Drawdown
42
Mean
70
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
No holdings or recent changes on file for this scheme yet.
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life Nifty Healthcare ETF
Aditya Birla Sun Life Mutual Fund
- 1Y
- +8.8%
- 3Y
- +21.0%
- Vol
- 15.0%
- Max DD
- -18.3%
- Sharpe
- 0.57
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher trailing returns
Aditya Birla Sun Life Nifty 200 Quality 30 ETF
Aditya Birla Sun Life Mutual Fund
- 1Y
- -9.4%
- 3Y
- +6.9%
- Vol
- 12.7%
- Max DD
- -22.5%
- Sharpe
- 0.17
- 3Y win
- +7%
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns
Axis BSE Sensex ETF
Axis Mutual Fund
- 1Y
- -11.9%
- 3Y
- +6.2%
- Vol
- 12.7%
- Max DD
- -16.0%
- Sharpe
- 0.23
- 3Y win
- 0%
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns
Mirae Asset BSE 200 Equal Weight ETF
Mirae Asset Mutual Fund
- 1Y
- -5.2%
- 3Y
- n/a
- Vol
- 15.2%
- Max DD
- -13.6%
- Sharpe
- 0.19
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns
Mirae Asset BSE Sensex ETF
Mirae Asset Mutual Fund
- 1Y
- -12.0%
- 3Y
- +6.3%
- Vol
- 13.3%
- Max DD
- -16.0%
- Sharpe
- 0.01
- 3Y win
- 0%
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns